MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $13.1M, a 30.7% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $48.2M, a 54.3% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.6M, a 85.3% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.7M, a 78.5% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.5M, a 57.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $48.2M $13.1M +$3.06M +30.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $45.1M $13.8M +$4.49M +48.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $40.7M $12.1M +$6.07M +101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $34.6M $9.34M +$3.35M +55.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $31.2M $9.99M +$5.25M +111% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $26M $9.27M +$4.96M +115% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $21M $5.99M +$2.36M +65.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $18.7M $6M +$3.77M +169% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $14.9M $4.74M +$1.17M +32.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $13.7M $4.31M +$1.93M +80.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $11.8M $3.63M +$1.35M +59.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.5M $2.23M -$19.5M -89.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $29.9M $3.57M +$1.72M +92.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $28.2M $2.38M +$1.81M +314% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $26.4M $2.28M +$1.77M +348% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $24.6M $21.7M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $1.85M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $576K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $508K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.